These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1586246)

  • 1. Antibodies to protein P in systemic lupus erythematosus.
    Teh LS; Bedwell AE; Isenberg DA; Gordon C; Emery P; Charles PJ; Harper M; Amos N; Williams BD
    Ann Rheum Dis; 1992 Apr; 51(4):489-94. PubMed ID: 1586246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus.
    Yoshio T; Masuyama J; Ikeda M; Tamai K; Hachiya T; Emori T; Mimori A; Takeda A; Minota S; Kano S
    J Rheumatol; 1995 Sep; 22(9):1681-7. PubMed ID: 8523345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies.
    Ghirardello A; Doria A; Zampieri S; Gerli R; Rapizzi E; Gambari PF
    Ann Rheum Dis; 2000 Dec; 59(12):975-81. PubMed ID: 11087701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus.
    Schneebaum AB; Singleton JD; West SG; Blodgett JK; Allen LG; Cheronis JC; Kotzin BL
    Am J Med; 1991 Jan; 90(1):54-62. PubMed ID: 1986591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between serum IgG antibodies to recombinant ribosomal P0 fusion protein and neuropsychiatric systemic lupus erythematosus.
    Hirohata S; Isshi K; Toyoshima S
    Arthritis Rheum; 1998 Apr; 41(4):745-7. PubMed ID: 9550489
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of serum IgG antibodies to recombinant P0 fusion protein with IgG antibodies to carboxyl-terminal 22 synthetic peptides and carboxyl-terminal 22 amino acid-deleted recombinant P0 fusion protein in patients with systemic lupus erythematosus.
    Yoshio T; Masuyama JI; Minota S; Iwamoto M; Mimori A; Takeda A; Okazaki H; Kano S
    Arthritis Rheum; 1997 Jul; 40(7):1364-5. PubMed ID: 9214440
    [No Abstract]   [Full Text] [Related]  

  • 7. Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus.
    Lin JL; Dubljevic V; Fritzler MJ; Toh BH
    Clin Exp Immunol; 2005 Jul; 141(1):155-64. PubMed ID: 15958082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
    Hirohata S; Arinuma Y; Takayama M; Yoshio T
    Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease.
    Tzioufas AG; Tzortzakis NG; Panou-Pomonis E; Boki KA; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
    Ann Rheum Dis; 2000 Feb; 59(2):99-104. PubMed ID: 10666163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of antibodies against the native ribosomal P protein complex and recombinant P0, P1, and P2 proteins in the diagnosis of Chinese patients with systemic lupus erythematosus.
    Li J; Shen Y; He J; Jia R; Wang X; Chen X; Wang D; Han L; Zhu L; Chi X; Saschenbrecker S; Dähnrich C; Stöcker W; Schlumberger W; Li ZG
    J Clin Lab Anal; 2013 Mar; 27(2):87-95. PubMed ID: 23400861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody.
    Watanabe T; Sato T; Uchiumi T; Arakawa M
    Lupus; 1996 Jun; 5(3):178-83. PubMed ID: 8803887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-P antibodies are associated with psychiatric and focal cerebral disorders in patients with systemic lupus erythematosus.
    Teh LS; Hay EM; Amos N; Black D; Huddy A; Creed F; Bernstein RM; Holt PJ; Williams BD
    Br J Rheumatol; 1993 Apr; 32(4):287-90. PubMed ID: 8461921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus.
    Isshi K; Hirohata S
    Arthritis Rheum; 1996 Sep; 39(9):1483-90. PubMed ID: 8814059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single anti-P ribosomal antibodies are not associated with lupus nephritis in patients suffering from active systemic lupus erythematosus.
    Quintana G; Coral-Alvarado P; Aroca G; Patarroyo PM; Chalem P; Iglesias-Gamarra A; Ruiz AI; Cervera R
    Autoimmun Rev; 2010 Sep; 9(11):750-5. PubMed ID: 20601199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus.
    Barkhudarova F; Dähnrich C; Rosemann A; Schneider U; Stöcker W; Burmester GR; Egerer K; Schlumberger W; Hiepe F; Biesen R
    Arthritis Res Ther; 2011 Feb; 13(1):R20. PubMed ID: 21310064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic benefit of antibodies against ribosomal proteins in systemic lupus erythematosus.
    Shi ZR; Han YF; Yin J; Zhang YP; Jiang ZX; Zheng L; Tan GZ; Wang L
    Adv Rheumatol; 2020 Aug; 60(1):45. PubMed ID: 32859277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between lupus psychosis and anti-ribosomal P protein antibodies.
    Bonfa E; Golombek SJ; Kaufman LD; Skelly S; Weissbach H; Brot N; Elkon KB
    N Engl J Med; 1987 Jul; 317(5):265-71. PubMed ID: 3496538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restricted specificity of anti-ribosomal P antibodies to SLE patients in Israel.
    Shovman O; Zandman-Goddard G; Gilburd B; Blank M; Ehrenfeld M; Bardechevski S; Stojanovich L; Langevitz P; Shoenfeld Y
    Clin Exp Rheumatol; 2006; 24(6):694-7. PubMed ID: 17207387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of acidic ribosomal phosphoproteins on the surface membrane of different tissues in autoimmune and normal mice which are the target molecules for anti-double-stranded DNA antibodies.
    Sun KH; Liu WT; Tang SJ; Tsai CY; Hsieh SC; Wu TH; Han SH; Yu CL
    Immunology; 1996 Mar; 87(3):362-71. PubMed ID: 8778020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays.
    Agmon-Levin N; Gilburd B; Kivity S; Katz BS; Flitman-Katzevman I; Shoenfeld N; Paran D; Langevitz P; Shoenfeld Y
    Isr Med Assoc J; 2009 Jul; 11(7):403-6. PubMed ID: 19911490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.